Serious Allergic Reactions Requiring Immediate Care
Lurbinectedin (brand name Zepzelca) can cause severe hypersensitivity reactions, including anaphylaxis, which demand instant medical attention. Symptoms often include sudden difficulty breathing, swelling of the face, lips, tongue or throat, rapid heartbeat, rash, hives, or low blood pressure. Stop treatment and seek emergency help if these occur, as they can be life-threatening.[1][2]
Why These Reactions Happen
Lurbinectedin, used for metastatic small cell lung cancer, triggers immune responses in some patients during or shortly after infusion. Premedication with antihistamines, steroids, and antiemetics is standard to reduce risk, but reactions still happen in about 1-5% of cases.[1][3]
Rarer But Critical Side Effects Needing Urgent Attention
- Rhabdomyolysis: Muscle breakdown causing severe pain, weakness, dark urine, or kidney issues—call emergency services immediately.
- Pneumonitis: Sudden shortness of breath, cough, or fever signaling lung inflammation.
- Infusion-related reactions: Fever, chills, or chest pain during administration.[1][2]
How Common Are These?
Most patients tolerate lurbinectedin, but severe events like anaphylaxis occur in <2% of infusions, per clinical data. Monitoring during the first two cycles is key.[3]
Patient Tips for Early Warning
Watch for symptoms within hours of infusion. Hospitals often have crash carts ready. Report any unusual fatigue, nausea escalation, or breathing changes to your doctor right away, even if not during infusion.[2]
Sources
[1]: FDA Zepzelca Label
[2]: Drugs.com Lurbinectedin Side Effects
[3]: ClinicalTrials.gov NCT02454972 Summary